Dae-Sung Kyoung, Jeongwoo Lee, Hyewon Nam, Moon Ho Park
{"title":"Dementia and COVID-19 Mortality in South Korea.","authors":"Dae-Sung Kyoung, Jeongwoo Lee, Hyewon Nam, Moon Ho Park","doi":"10.12779/dnd.2021.20.3.38","DOIUrl":null,"url":null,"abstract":"Coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 has continued to influence healthcare dynamics, social patterns, and economic systems worldwide. As of mid-March 2021, COVID-19 has already resulted in more than 97,000 infections and 1,690 deaths in South Korea. To date, no treatment has demonstrated its effectiveness with a sufficient level of scientific evidence. Fortunately, a major milestone in the efforts against this pandemic was the rapid and successful development of different vaccines against COVID-19. However, the development of vaccines alone cannot overcome COVID-19. Until the transition to normalcy is achieved, appropriate management for highrisk groups will continue to be one of the main strategies for combating COVID-19.","PeriodicalId":72779,"journal":{"name":"Dementia and neurocognitive disorders","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/08/54/dnd-20-38.PMC8326307.pdf","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dementia and neurocognitive disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12779/dnd.2021.20.3.38","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/5/31 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
Coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 has continued to influence healthcare dynamics, social patterns, and economic systems worldwide. As of mid-March 2021, COVID-19 has already resulted in more than 97,000 infections and 1,690 deaths in South Korea. To date, no treatment has demonstrated its effectiveness with a sufficient level of scientific evidence. Fortunately, a major milestone in the efforts against this pandemic was the rapid and successful development of different vaccines against COVID-19. However, the development of vaccines alone cannot overcome COVID-19. Until the transition to normalcy is achieved, appropriate management for highrisk groups will continue to be one of the main strategies for combating COVID-19.